Elevance Health (ELV) Depreciation & Amortization (CF) (2010 - 2026)

Elevance Health (ELV) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $354.0 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 5.09% year-over-year to $354.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 6.41% YoY) and the FY2025 annual result came in at $1.5 billion, up 10.98% from the prior year.
• Depreciation & Amortization (CF) eased to $354.0 million in Q1 2026 per ELV's latest filing, from $406.0 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $473.0 million in Q4 2022 and bottomed at $329.0 million in Q3 2024.
• The 5-year median for Depreciation & Amortization (CF) is $393.0 million (2022), against an average of $394.9 million.
• The widest annual swing landed in 2022, when Depreciation & Amortization (CF) soared 31.39%; it then declined 28.35% in 2024.
• Tracing ELV's Depreciation & Amortization (CF) over 5 years: stood at $473.0 million in 2022, then dropped by 10.36% to $424.0 million in 2023, then fell by 6.13% to $398.0 million in 2024, then advanced by 2.01% to $406.0 million in 2025, then fell by 12.81% to $354.0 million in 2026.
• Per Business Quant, the three latest ELV Depreciation & Amortization (CF) figures stand at $354.0 million (Q1 2026), $406.0 million (Q4 2025), and $387.0 million (Q3 2025).

Peer Comparison